Literature DB >> 17703424

Capsular polysaccharide masks clumping factor A-mediated adherence of Staphylococcus aureus to fibrinogen and platelets.

Allison L Risley1, Anthony Loughman, Colette Cywes-Bentley, Timothy J Foster, Jean C Lee.   

Abstract

BACKGROUND: Clumping factor A (ClfA) is a Staphylococcus aureus cell wall-associated adhesin that mediates staphylococcal binding to fibrinogen and platelets. Our goals were to determine whether expression of capsular polysaccharide (CP) affected ClfA-mediated adherence of S. aureus and to assess whether the length of the ClfA repeat region influenced this interaction.
METHODS: ClfA constructs with repeat regions of different lengths were introduced into isogenic S. aureus strains that expressed CP5, CP8, or no CP. S. aureus binding to fibrinogen was assessed in rabbit plasma and on fibrinogen-coated microtiter plates. Adherence of S. aureus strains to platelets was evaluated by flow cytometry and confocal microscopy.
RESULTS: As the length of the ClfA repeat region increased, binding of acapsular S. aureus to fibrinogen-coated microtiter plates was enhanced. By contrast, encapsulated S. aureus expressing the full-length ClfA were poorly adherent. The acapsular S. aureus mutant strain showed a 2-fold increase in platelet binding, compared with the isogenic encapsulated strains. By contrast, platelet aggregation was unaffected by CP production.
CONCLUSION: CP expression inhibits S. aureus ClfA-mediated binding to fibrinogen and platelets, and a full-length repeat region cannot overcome this inhibition. These findings have important implications for vaccine development, given that CP may mask surface adhesins.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17703424     DOI: 10.1086/520932

Source DB:  PubMed          Journal:  J Infect Dis        ISSN: 0022-1899            Impact factor:   5.226


  15 in total

1.  False-negative test results in the Slidex Staph Plus (bioMérieux) agglutination test are mainly caused by spa-type t001 and t001-related strains.

Authors:  F Szabados; J Woloszyn; M Kaase; S G Gatermann
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2010-10-09       Impact factor: 3.267

2.  Regional profiling for determination of genotype diversity of mastitis-specific Staphylococcus aureus lineage in Canada by use of clumping factor A, pulsed-field gel electrophoresis, and spa typing.

Authors:  Kamaleldin B Said; Johanne Ismail; Jennifer Campbell; Michael R Mulvey; Anne-Marie Bourgault; Serge Messier; Xin Zhao
Journal:  J Clin Microbiol       Date:  2009-12-02       Impact factor: 5.948

3.  RbsR Activates Capsule but Represses the rbsUDK Operon in Staphylococcus aureus.

Authors:  Mei G Lei; Chia Y Lee
Journal:  J Bacteriol       Date:  2015-09-08       Impact factor: 3.490

4.  Antibacterial Activity of Electrospun Polyacrylonitrile Copper Nanoparticle Nanofibers on Antibiotic Resistant Pathogens and Methicillin Resistant Staphylococcus aureus (MRSA).

Authors:  William B Wang; Jude C Clapper
Journal:  Nanomaterials (Basel)       Date:  2022-06-22       Impact factor: 5.719

Review 5.  Staphylococcus aureus Aggregation and Coagulation Mechanisms, and Their Function in Host-Pathogen Interactions.

Authors:  H A Crosby; J Kwiecinski; A R Horswill
Journal:  Adv Appl Microbiol       Date:  2016-08-04       Impact factor: 5.086

6.  Proteomic and transcriptomic profiling of Staphylococcus aureus surface LPXTG-proteins: correlation with agr genotypes and adherence phenotypes.

Authors:  Mathilde Ythier; Grégory Resch; Patrice Waridel; Alexandre Panchaud; Aurélie Gfeller; Paul Majcherczyk; Manfredo Quadroni; Philippe Moreillon
Journal:  Mol Cell Proteomics       Date:  2012-07-25       Impact factor: 5.911

Review 7.  Reduced vancomycin susceptibility in Staphylococcus aureus, including vancomycin-intermediate and heterogeneous vancomycin-intermediate strains: resistance mechanisms, laboratory detection, and clinical implications.

Authors:  Benjamin P Howden; John K Davies; Paul D R Johnson; Timothy P Stinear; M Lindsay Grayson
Journal:  Clin Microbiol Rev       Date:  2010-01       Impact factor: 26.132

8.  Novel synthetic (poly)glycerolphosphate-based antistaphylococcal conjugate vaccine.

Authors:  Quanyi Chen; Jay Dintaman; Andrew Lees; Goutam Sen; David Schwartz; Mark E Shirtliff; Saeyoung Park; Jean C Lee; James J Mond; Clifford M Snapper
Journal:  Infect Immun       Date:  2013-05-06       Impact factor: 3.441

9.  Synthesis and evaluation of a conjugate vaccine composed of Staphylococcus aureus poly-N-acetyl-glucosamine and clumping factor A.

Authors:  Tomás Maira-Litrán; Leticia V Bentancor; Cagla Bozkurt-Guzel; Jennifer M O'Malley; Colette Cywes-Bentley; Gerald B Pier
Journal:  PLoS One       Date:  2012-09-06       Impact factor: 3.240

10.  Different bacterial gene expression patterns and attenuated host immune responses are associated with the evolution of low-level vancomycin resistance during persistent methicillin-resistant Staphylococcus aureus bacteraemia.

Authors:  Benjamin P Howden; Danielle J Smith; Ashley Mansell; Paul D R Johnson; Peter B Ward; Timothy P Stinear; John K Davies
Journal:  BMC Microbiol       Date:  2008-02-27       Impact factor: 3.605

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.